Literature DB >> 11825401

[Long-term results of combined splenorenal shunt and porta-azygos devascularization in patients with portal hypertension].

D Gao1, Z He, J Wu, Q Ma, H Song, L Mei, Y Wu.   

Abstract

OBJECTIVE: To investigate the long-term effects of combined splenorenal shunt and porta-azygos devascularization in patients with portal hypertension.
METHOD: We analysed retrospectively the follow-up results of 140 portal hypertensive patients undergoing the combined therapy in our hospital from April 1978 to April 1997. Changes of portal hemodynamics were studied by Doppler Flowmeter and DSA pre- and-postoperatively and direct FPP measurement intraoperatively. RESULT: The operative mortality was 3.6%. No rebleeding was noted in a short period and rebleeding rate was 8.3% in a long term follow-up. The rate of postoperative hepatic encephalopathy was 5.0%. The long-term survival rate of 5-, 10- and 15-years was 83.6%, 64.5% and 54.5%, respectively. After operation FPP and PVP decreased significantly (P < 0.01) and FPP maintained at the level of 3.2 +/- 0.4 kPa.
CONCLUSION: The combined procedure is a rational and practical procedure for the treatment of patients with portal hypertension.

Entities:  

Mesh:

Year:  1998        PMID: 11825401

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  2 in total

1.  Clinical analysis of surgical treatment of portal hypertension.

Authors:  Xin-Bao Xu; Jing-Xiu Cai; Xi-Sheng Leng; Jia-Hong Dong; Ji-Ye Zhu; Zhen-Ping He; Fu-Shun Wang; Ji-Run Peng; Ben-Li Han; Ru-Yu Du
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

2.  Impact of Maternal Selenium Status on Infant Outcome during the First 6 Months of Life.

Authors:  Kristin Varsi; Bjørn Bolann; Ingrid Torsvik; Tina Constanse Rosvold Eik; Paul Johan Høl; Anne-Lise Bjørke-Monsen
Journal:  Nutrients       Date:  2017-05-11       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.